Literature DB >> 18499843

Microvascular architecture of breast lesions: evaluation with contrast-enhanced ultrasonographic micro flow imaging.

Jing Du1, Feng-Hua Li, Hua Fang, Jian-Guo Xia, Cai-Xia Zhu.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the effectiveness of micro flow imaging (MFI) of the microvascular architecture with contrast-enhanced ultrasonography for classification of breast lesions as benign or malignant and the microvascular architectural patterns.
METHODS: Contrast-enhanced ultrasonography and MFI were performed in 61 women with breast lesions. The microvascular morphologic and distribution features of the breast tumors were evaluated with MFI. Receiver operating characteristic curve analysis was used to evaluate the diagnostic value of MFI, and the microvascular architectural patterns were analyzed.
RESULTS: Surgical pathologic analysis showed 29 benign and 32 malignant lesions. For MFI, the area under the receiver operating characteristic curve (A(z)) value for the overall features of the blood vessels for classification of breast lesions was 0.94. The accuracy, sensitivity, and specificity were 90.2% (55/61), 93.8% (30/32), and 86.2% (25/29), respectively. The A(z) value for the morphologic and distribution features of peripheral blood vessels was 0.91, which was significantly higher than the A(z) value for the morphologic and distribution features of interior vessels (P= .019). The microvascular architecture of the 61 lesions was categorized into 3 patterns: treelike, root hair-like, and crab claw-like. Benign lesions mainly displayed the treelike pattern (17 [58.6%]); malignant lesions tended to display the crab claw-like pattern (20 [62.5%]); and the root hair-like pattern was shown in both benign and malignant lesions (11 [37.9%] and 8 [25%], respectively). The microvascular architecture showed significant differences between benign and malignant lesions (P< .001).
CONCLUSIONS: Micro flow imaging can clearly delineate the microvascular architecture of breast lesions and can aid in discrimination between benign and malignant breast lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499843     DOI: 10.7863/jum.2008.27.6.833

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  25 in total

1.  Contrast-Enhanced Color Doppler Ultrasonography for Preoperative Evaluation of Sentinel Lymph Node in Breast Cancer Patients.

Authors:  Dionysios Dellaportas; Andreas Koureas; John Contis; Panagis M Lykoudis; Irene Vraka; Dimitrios Psychogios; Agatha Kondi-Pafiti; Dionysios K Voros
Journal:  Breast Care (Basel)       Date:  2015-07-10       Impact factor: 2.860

2.  Usefulness of contrast-enhanced ultrasonography for intracystic breast tumors: a report of three cases.

Authors:  Kumiko Kato; Hiroko Nogi; Tomoyuki Ohta; Makiko Kamio; Yasuo Toriumi; Norio Nakata; Ken Uchida; Yukio Miyamoto; Hiroshi Takeyama
Journal:  J Med Ultrason (2001)       Date:  2014-02-21       Impact factor: 1.314

3.  Differentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model.

Authors:  Hanping Wu; Ravi B Patel; Yuanyi Zheng; Luis Solorio; Tianyi M Krupka; Nicholas P Ziats; John R Haaga; Agata A Exner
Journal:  Ultrasound Med Biol       Date:  2012-01-21       Impact factor: 2.998

4.  Phase II clinical study of DD-723 (perflubutane): dose-response study in patients with breast tumors.

Authors:  Yukio Miyamoto; Toshikazu Ito; Etsuo Takada; Kiyoka Omoto; Toshiko Hirai; Ryuzo Sekiguchi; Toshitaka Okuno; Shinsaku Kanazawa; Norio Nakata; Takao Igarashi
Journal:  J Med Ultrason (2001)       Date:  2012-02-03       Impact factor: 1.314

5.  Initial experience of transcranial contrast-enhanced ultrasonography with Sonazoid in the evaluation of microvascular brain anatomy.

Authors:  Kozue Saito; Toshiko Hirai; Hajime Ohishi; Satoshi Ueno
Journal:  J Med Ultrason (2001)       Date:  2009-07-31       Impact factor: 1.314

6.  Predictive model for contrast-enhanced ultrasound of the breast: Is it feasible in malignant risk assessment of breast imaging reporting and data system 4 lesions?

Authors:  Jun Luo; Ji-Dong Chen; Qing Chen; Lin-Xian Yue; Guo Zhou; Cheng Lan; Yi Li; Chi-Hua Wu; Jing-Qiao Lu
Journal:  World J Radiol       Date:  2016-06-28

7.  Contrast enhanced maximum intensity projection ultrasound imaging for assessing angiogenesis in murine glioma and breast tumor models: A comparative study.

Authors:  Flemming Forsberg; Raymond J Ro; Traci B Fox; Ji-Bin Liu; See-Ying Chiou; Magdalena Potoczek; Barry B Goldberg
Journal:  Ultrasonics       Date:  2010-11-18       Impact factor: 2.890

8.  Superb microvascular imaging in diagnosis of breast lesions: a comparative study with contrast-enhanced ultrasonographic microvascular imaging.

Authors:  Xiao-Yun Xiao; Xin Chen; Xiao-Feng Guan; Huan Wu; Wei Qin; Bao-Ming Luo
Journal:  Br J Radiol       Date:  2016-08-16       Impact factor: 3.039

9.  Homogeneously enhancing breast lesions on contrast enhanced US: differential diagnosis by conventional and contrast enhanced US findings.

Authors:  Ritsuko Fujimitsu; Mikiko Shimakura; Hiroshi Urakawa; Ayako Morita; Yoshinobu Shinagawa; Keiko Sakamoto; Kengo Yoshimitsu
Journal:  Jpn J Radiol       Date:  2016-05-03       Impact factor: 2.374

10.  Diagnostic value of contrast-enhanced ultrasound parametric imaging in breast tumors.

Authors:  Zhang Yuan; Jiang Quan; Zhang Yunxiao; Chen Jian; He Zhu; Gong Liping
Journal:  J Breast Cancer       Date:  2013-06-28       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.